The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer Brokerages are positive on prospects of Glenmark Life Sciences IPO. BusinessToday.In
Updated Jul 28, 2021, 10:27 AM IST
The initial public offer (IPO) of Glenmark Life Sciences was fully subscribed on its first day on Tuesday. The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer.
The portion reserved for retail investors was subscribed 5.16 times.
Portion allocated for non-institutional investors was subscribed 85 percent. Qualified institutional buyers put in bids for 10,540 equity shares against their reserved portion of 42.42 lakh equity shares.
The IPO will close on July 29. Price band for the offer has been fixed at Rs 695-720 per equity share.
IPO Update: Glenmark Life Sciences IPO subscribed 3 27 times on Day 2
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
DNA Explainer: Why foreign funds linked to Adani Group companies are under the scanner
dnaindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dnaindia.com Daily Mail and Mail on Sunday newspapers.
Unichem Laboratories share rises 8% on US FDA approval for Apremilast tablets
The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE
BusinessToday.In | February 19, 2021 | Updated 17:12 IST
Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.
Unichem Laboratories share price rose nearly 8 percent today after United States Food and Drug Administration s (US FDA) awarded approval for its Apremilast tablets. The stock has gained 6.9% in the last 4 days. The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE.
Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The share has gained 131.55% in one year and risen 22.66% since the beginning of this year. Later, the small cap stock closed 4.94% or Rs 15.10 higher at Rs 320.70.